Business
- Poultry Vaccines Market to Grow at 7.6% CAGR Through 2033
22 Jul, 2024 - Valneva gets $41m grant to roll out chikungunya vaccine
22 Jul, 2024 - Valneva Secures Multi-Million Grant for Vaccine Access
22 Jul, 2024 - Flu Vaccine Research:CAGR of 4.8% during the forecast period
22 Jul, 2024 - Global Cancer Vaccine Market, Vaccine Price, Dosage, Sales and Clinical Trials Outlook 2029
22 Jul, 2024 - Rapid Growth and Future Potential of Intramuscular Vaccine
22 Jul, 2024 - mRNA Vaccines and mRNA Drugs Industry to Witness Massive Growth (2024-2034) |Thermo Fisher, Merck, Qiagen N.V., CureVac,
21 Jul, 2024 - Non-invasive Vaccine Market Growth Report |Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai Uni
21 Jul, 2024 - Measles Combined with Live Attenuated Vaccine Market Growing Rapidly by-GSK, Merck, Beijing Institute of Biological Prod
21 Jul, 2024 - Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market (2024-2034):Sanofi, GSK, KM Biologics, Serum Institu
20 Jul, 2024 - Merz will strengthen the competitiveness of the European pharmaceutical industry
19 Jul, 2024 - Conjugate Vaccines Market Size Analysis, Strategic Assessment, Market Growth and Forecasts to 2030
19 Jul, 2024 - Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
17 Jul, 2024 - The Liverpool vaccine factory preparing for a H5N1 bird flu pandemic
16 Jul, 2024 - Global Pediatric Drugs and Vaccines Strategic Research Report 2024: A $156.7 Billion Market by 2030 – Advancements in Drug Formulation Propel Growth
16 Jul, 2024 - Roth/MKM initiates Buy rating on GeoVax Labs stock, forecasts strong vaccine revenue
16 Jul, 2024 - GSK launches 1st meningococcal B vaccine Bexsero in Korea
16 Jul, 2024 - Global Pediatric Drugs and Vaccines Strategic Research
16 Jul, 2024 - Acuitas’ Inventorship Suit Clouds Alnylam Case on Pfizer Vaccine
15 Jul, 2024 - Serum Institute’s New “High Efficacy” Malaria Vaccine Rolls Out In Africa
15 Jul, 2024 - Poliomyelitis Market Estimated to Reach a CAGR of 5.04% during 2024-2034, Impelled by Introduction of New Vaccine Formulations
15 Jul, 2024 - mRNA Vaccine Market Size Forecasted to Achieve USD 9.6 Bn by 2034
15 Jul, 2024
0 Comments